Literature DB >> 9049535

Myocardial preconditioning. What have we learned?

M S Sumeray1, D M Yellon.   

Abstract

It is now 10 years since the phenomenon termed 'ischaemic preconditioning' was formally recognised. The possibility that an innate mechanism of myocardial protection might be inducible in the human heart has generated considerable excitement and enthusiastic research. This has led to a more detailed understanding of the mechanisms underlying ischaemia-reperfusion injury and has provided reason to believe that the progress of myocardial necrosis might be modified by invoking a protective adaptation within the myocyte. Considerable progress has been made towards the identification of cell triggers and transduction mechanisms that may be involved in the process of preconditioning. It is likely that future studies will examine the effect of several classes of pharmacological agents that may prove capable of mimicking the protective effect of sub-lethal ischaemia.

Entities:  

Mesh:

Year:  1997        PMID: 9049535     DOI: 10.1093/eurheartj/18.suppl_a.8

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  4 in total

1.  The sulphonylurea glibenclamide inhibits voltage dependent potassium currents in human atrial and ventricular myocytes.

Authors:  P Schaffer; B Pelzmann; E Bernhart; P Lang; H Mächler; B Rigler; B Koidl
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

Review 2.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

3.  Protocol: does sodium nitrite administration reduce ischaemia-reperfusion injury in patients presenting with acute ST segment elevation myocardial infarction? Nitrites in acute myocardial infarction (NIAMI).

Authors:  Nishat Siddiqi; Margaret Bruce; Christopher J Neil; Baljit Jagpal; Graeme Maclennon; Seonaidh C Cotton; Sofia A Papadopoulo; Nicholas Bunce; Pitt Lim; Konstantin Schwarz; Satnam Singh; David Hildick-Smith; John D Horowitz; Melanie Madhani; Nicholas Boon; Juan-Carlos Kaski; Dana Dawson; Michael P Frenneaux
Journal:  J Transl Med       Date:  2013-05-06       Impact factor: 5.531

4.  Stimulation of the p38 mitogen-activated protein kinase pathway in neonatal rat ventricular myocytes by the G protein-coupled receptor agonists, endothelin-1 and phenylephrine: a role in cardiac myocyte hypertrophy?

Authors:  A Clerk; A Michael; P H Sugden
Journal:  J Cell Biol       Date:  1998-07-27       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.